https://pubmed.ncbi.nlm.nih.gov/38112840
error code: 504
https://pubmed.ncbi.nlm.nih.gov/38112837
The abstract discusses the challenges and uncertainties in diagnosing villous atrophy, a key characteristic of celiac disease, highlighting the need for more precise diagnostic criteria and methods.
https://pubmed.ncbi.nlm.nih.gov/38112836
This abstract suggests that hypermobility and trauma may be interconnected and contribute to certain health outcomes, but further research is needed to determine the nature of this relationship.
https://pubmed.ncbi.nlm.nih.gov/38112834
Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome patients with IBS and functional dyspepsia report more traumatic exposures and adverse childhood experiences than those without these gut-brain interaction disorders.
https://pubmed.ncbi.nlm.nih.gov/38112833
The BELIEVE trial is a platform study in Japan using comprehensive genomic profiling to improve access to off-label oncology drugs for patients with actionable genetic abnormalities, contributing to precision medicine and collaboration between industry and academia.
https://pubmed.ncbi.nlm.nih.gov/38112831
The study found that analyzing folate receptor-positive circulating tumor cells (FR+CTCs) can accurately distinguish colorectal cancer (CRC) from benign colorectal diseases, with excellent diagnostic efficiency in screening CRC, and the potential to predict tumor stage and guide treatment.